Page last updated: 2024-09-04

rp 73401 and 9-(2-hydroxy-3-nonyl)adenine

rp 73401 has been researched along with 9-(2-hydroxy-3-nonyl)adenine in 2 studies

Compound Research Comparison

Studies (rp 73401)	Trials (rp 73401)	Recent Studies (post-2010) (rp 73401)	Studies (9-(2-hydroxy-3-nonyl)adenine)	Trials (9-(2-hydroxy-3-nonyl)adenine)	Recent Studies (post-2010) (9-(2-hydroxy-3-nonyl)adenine)
92	0	23	428	1	33
92	0	23	30	0	11

Protein Interaction Comparison

Protein	Taxonomy	9-(2-hydroxy-3-nonyl)adenine (IC50)
cGMP-dependent 3',5'-cyclic phosphodiesterase	Homo sapiens (human)	2.145
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	Homo sapiens (human)	0.8
cGMP-specific 3',5'-cyclic phosphodiesterase	Homo sapiens (human)	0.8
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens (human)	0.8
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens (human)	0.8

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Favot, L; Holl, V; Keravis, T; Le Bec, A; Lugnier, C	1
de Esch, IJ; de Graaf, C; Jansen, C; Kanev, GK; Kooistra, AJ; Leurs, R	1

Other Studies

2 other study(ies) available for rp 73401 and 9-(2-hydroxy-3-nonyl)adenine

Article	Year
VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors. Thrombosis and haemostasis, 2003, Volume: 90, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Allantois; Animals; Benzamides; Cell Cycle; Cell Division; Cell Movement; Cells, Cultured; Chick Embryo; Chorion; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 4; Endothelium, Vascular; Enzyme Inhibitors; Humans; Intracellular Membranes; Neovascularization, Physiologic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridines; Umbilical Veins; Vascular Endothelial Growth Factor A	2003
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design. Journal of medicinal chemistry, 2016, Aug-11, Volume: 59, Issue:15 Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship	2016

Article

Year

VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors.

Thrombosis and haemostasis, 2003, Volume: 90, Issue:2

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Adenine; Allantois; Animals; Benzamides; Cell Cycle; Cell Division; Cell Movement; Cells, Cultured; Chick Embryo; Chorion; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 4; Endothelium, Vascular; Enzyme Inhibitors; Humans; Intracellular Membranes; Neovascularization, Physiologic; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridines; Umbilical Veins; Vascular Endothelial Growth Factor A

2003

PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.

Journal of medicinal chemistry, 2016, Aug-11, Volume: 59, Issue:15

Topics: Databases, Protein; Dose-Response Relationship, Drug; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship

2016